Drugs / buprenorphine/naloxone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05944952 | Jun → Dec 2024 overdue | substance-related disorder | Friends Research Institute, Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | buprenorphine/naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05944952 ↗ |